Rogers; Bruce N.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rogers; Bruce N..The latest application filed is for "inhibiting (alpha-v)(beta-6) integrin".
Company Profile
10.14.32
- Rogers; Bruce N. - Belmont MA
- Rogers; Bruce N. - Mystic CT
- Rogers; Bruce N. - Portage MI
Patent Activity
| Patent | Date |
|---|---|
| Inhibiting human integrin (alpha-4) (beta-7) Grant 11,370,773 - Bursavich , et al. June 28, 2 | 2022-06-28 |
| Inhibiting (alpha-v)(beta-6) Integrin App 20220073511 - Harrison; Bryce A. ; et al. | 2022-03-10 |
| Antagonists of human integrin (.alpha.4)(.beta.7) Grant 11,174,228 - Bursavich , et al. November 16, 2 | 2021-11-16 |
| Inhibitors Of (alpha-v)(beta-6) Integrin App 20210284640 - Harrison; Bryce A. ; et al. | 2021-09-16 |
| Inhibitors Of (alpha-v)(beta-6) Integrin App 20210276975 - Brewer; Mark ; et al. | 2021-09-09 |
| Inhibiting human integrin (.alpha.-4) (.beta.-7) Grant 11,104,661 - Bursavich , et al. August 31, 2 | 2021-08-31 |
| Inhibitors of (.alpha.-v)(.beta.-6) integrin Grant 11,046,669 - Harrison , et al. June 29, 2 | 2021-06-29 |
| Inhibitors of (.alpha.-v)(.beta.-6) integrin Grant 11,046,685 - Harrison , et al. June 29, 2 | 2021-06-29 |
| Inhibitors of (alpha-v)(beta-6) integrin Grant 11,040,955 - Brewer , et al. June 22, 2 | 2021-06-22 |
| Inhibiting (.alpha.-V)(.beta.-6) integrin Grant 11,021,480 - Harrison , et al. June 1, 2 | 2021-06-01 |
| Antagonists Of Human Integrin (alpha4)(beta7) App 20200385352 - Bursavich; Matthew G. ; et al. | 2020-12-10 |
| Inhibiting (alpha-v)(beta-6) Integrin App 20200385384 - Harrison; Bryce A. ; et al. | 2020-12-10 |
| Inhibiting (alpha-v)(beta-6) Integrin App 20200354359 - Harrison; Bryce A. ; et al. | 2020-11-12 |
| Antagonists of human integrin .alpha.4.beta.7 Grant 10,759,756 - Bursavich , et al. Sep | 2020-09-01 |
| Inhibitors Of (alpha-v)(beta-6) Integrin App 20200157075 - Harrison; Bryce A. ; et al. | 2020-05-21 |
| Inhibitors Of (alpha-v)(beta-6) Integrin App 20200087299 - Brewer; Mark ; et al. | 2020-03-19 |
| Inhibiting (alpha-v)(beta-6) Integrin App 20200071322 - Harrison; Bryce A. ; et al. | 2020-03-05 |
| Inhibitors Of (alpha-v)(beta-6) Integrin App 20200002334 - Harrison; Bryce A. ; et al. | 2020-01-02 |
| Antagonists Of Human Integrin (alpha4)(beta7) App 20190315692 - Bursavich; Matthew G. ; et al. | 2019-10-17 |
| Inhibitors Of (alpha-v)(beta-6) Integrin App 20180244648 - Harrison; Bryce A. ; et al. | 2018-08-30 |
| Azabenzimidazolyl Compounds App 20080312271 - Efremov; Ivan ; et al. | 2008-12-18 |
| Benzimidazolyl Compounds App 20080280933 - Efremov; Ivan ; et al. | 2008-11-13 |
| Azabenzoxazoles for the treatment of CNS disorders App 20060173179 - Rogers; Bruce N. ; et al. | 2006-08-03 |
| Azabenzoxazoles for the treatment of CNS disorders App 20060166974 - Rogers; Bruce N. ; et al. | 2006-07-27 |
| Treatment of diseases with alpha-7nACh receptor full agonists App 20060019984 - Groppi; Vincent E. ; et al. | 2006-01-26 |
| Tetracyclic azepinoindole compounds App 20050282796 - Acker, Brad A. ; et al. | 2005-12-22 |
| Positive allosteric modulators of the nicotinic acetylcholine receptor App 20050250816 - Piotrowski, David W. ; et al. | 2005-11-10 |
| Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease App 20050215584 - Rogers, Bruce N. ; et al. | 2005-09-29 |
| Azabicyclic-substituted-heteroaryl compounds for the treatment of disease Grant 6,919,359 - Piotrowski , et al. July 19, 2 | 2005-07-19 |
| Treatment of attention defecit hyperactivity disorder App 20050107425 - Rogers, Bruce N. ; et al. | 2005-05-19 |
| Tetracyclic azepinoindole compounds Grant 6,875,762 - Hester , et al. April 5, 2 | 2005-04-05 |
| Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease Grant 6,858,613 - Rogers , et al. February 22, 2 | 2005-02-22 |
| Positive allosteric modulators of the nicotinic acetylcholine receptor App 20040254373 - Piotrowski, David W. ; et al. | 2004-12-16 |
| Positive allosteric modulators of the nicotinic acetylcholine receptor App 20040249150 - Piotrowski, David W. ; et al. | 2004-12-09 |
| Tetracyclic azepinoindole compounds App 20040138202 - Hester, Jackson B. ; et al. | 2004-07-15 |
| Positive allosteric modulators of the nicotinic acetylcholine receptor App 20030236287 - Piotrowski, David W. ; et al. | 2003-12-25 |
| Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease App 20030236264 - Rogers, Bruce N. ; et al. | 2003-12-25 |
| Azabicyclic-substituted-heteroaryl compounds for the treatment of disease App 20030207913 - Piotrowski, David W. ; et al. | 2003-11-06 |
| Quinuclidine-substituted heteroaryl moieties for treatment of disease Grant 6,599,916 - Myers , et al. July 29, 2 | 2003-07-29 |
| Substituted-heteroaryl-7-aza[2.2.1] Bycycloheptanes For The Treatment Of Desease App 20030069290 - Wishka, Donn G. ; et al. | 2003-04-10 |
| Quinuclidine-substituted heteroaryl moieties for treatment of disease Grant 6,500,840 - Myers , et al. December 31, 2 | 2002-12-31 |
| Tetracyclic azepinoindole compounds App 20020198190 - Hester, Jackson B. ; et al. | 2002-12-26 |
| Quinuclidine-substituted heteroaryl moieties for treatment of disease App 20020091135 - Myers, Jason K. ; et al. | 2002-07-11 |
| Tetracyclic azepinoindole compounds Grant 6,407,092 - Hester , et al. June 18, 2 | 2002-06-18 |
| Quinuclidine-substituted heteroaryl moieties for treatment of disease App 20020042429 - Myers, Jason K. ; et al. | 2002-04-11 |
| Quinuclidine-substituted heteroaryl moieties for treatment of disease App 20020042428 - Myers, Jason K. ; et al. | 2002-04-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 